Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 117 results for "Alembic Ltd"

Alembic Pharmaceuticals gets USFDA nod for erectile dysfunction drug
Money Control

Alembic Pharmaceuticals gets USFDA nod for erectile dysfunctio...

The approved product is therapeutically equivalent to the reference listed drug product Levitra tablets of Bayer Healthcare Pharmaceuticals Inc. Money Control, 14 hours ago

1 images for "Alembic Ltd"

Economic Times, 5 months ago
Money Control

In pics | Stocks in the news: BSE, TRF, Infosys, Bandhan Bank, Exide Industries, Sagar Cements

KEC International | Alembic Pharma | Bank of India | Dhanlaxmi Bank | Indian Overseas Bank are also in focus today.
 Money Control1 day ago In pics | Stocks in the news: LT, Vodafone Idea, Uflex, Tata Steel, SBI, JSPL, Alembic Pharma  Money Control1 week ago Stocks in the news: Reliance Ind, ICICI Bank, Future Retail, Indiabulls Housing, YES Bank, Biocon and NBCC  Economic Times1 month ago Indian drug firms recall products in US market  Times of India1 month ago
Money Control

Alembic Pharma Standalone June 2020 Net Sales at Rs 1,258.43 crore, up 40.33% Y-o-Y

re in June 2020 up 40.33% from Rs. 896.74 crore in June 2019. Quarterly Net Profit at Rs. 318.64 crore in June 2020 up 105.28% from Rs. 155.22 crore in June 2019. EBITDA stands at Rs. 423.51 crore in June 2020 up 85.78% from Rs. 227.96 crore in June 2019.
 Money Control1 week ago Alembic Pharma Q1 profit more than doubles to ₹301.46 crore  Hindu Business Line2 weeks ago Alembic Pharma Q1 results: Profit jumps over 2-folds to Rs 301.46 crore  Economic Times2 weeks ago Alembic Pharma Q1 profit rises to ₹319 crore  Hindu Business Line2 weeks ago
Economic Times

Alembic Pharma gets board approval to raise up to Rs 1,000 crore via QIP

The board, at its meeting held on Monday, has accorded its approval to raise up to Rs 1,000 crore through a QIP issue of equity shares, Alembic Pharmaceuticals said in a regulatory filing. Further, the board has delegated its authority to a fund-raising ...
 Economic Times1 week ago
Economic Times

Alembic set to raise $150-200 million via stake sale

Alembic launched about 22 generic drugs in the US in the previous fiscal year, with a further 10 products planned for launch in the first half of the current financial year. It has a strong presence in the anti-diabetic, cardiology, nephrology, gynaecology, ...
 Economic Times1 week ago
Economic Times

Board Meetings Today: Larsen & Toubro, Bajaj Auto, Bajaj Holdings, Alembic Pharma and Jindal Steel

There are corporate actions that often bring material changes to a company, directly affecting stakeholders. Corporate actions can often hold a lot of cues not just about how a business is doing but also how the stock is going to perform in the near term.
 Economic Times2 weeks ago

Indian Indices Erase Gains; Energy & FMCG Stocks Under Pressure

Posted by Equitymaster Share markets in India �have erased early morning gains but are still trading on a positive note. Benchmark indices opened on a strong note today tracking gains in global equities, amid hopes of another stimulus package in the US to ...
 Equitymaster.com13 hours ago

ALEMBIC PHARMA Share Price Up by 5%; BSE HEALTHCARE Index Down 0.3%

Posted by Equitymaster ALEMBIC PHARMA share price has zoomed 5% and is presently trading at Rs 1,033. Meanwhile, the BSE HEALTHCARE Index is at 17,193 (down 0.3%). Among the top Gainers in the BSE HEALTHCARE Index today are ALEMBIC PHARMA (up 5.1%) and SHILPA ...
 Equitymaster.com2 weeks ago Alembic Pharma share price hits 52-week high on tentative US FDA approval for diabetes drug  Money Control2 weeks ago ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Down 0.1%  Equitymaster.com2 weeks ago Alembic Pharma hits 52-week high on final USFDA approval for Deferasirox tablets  Money Control1 month ago
Money Control

Hedge fund Sylebra acquires 1.1% stake in PVR, promoter Nirayu buys 1.5% in Alembic

Total promoter and promoter group shareholding in Alembic stood at 67.62 percent, including Nirayu#39;s 59.80 percent as of March 31
 Money Control2 months ago

Share market update: 15 stocks hit 52-week highs on NSE

Ruchi Soya Inds and Alembic Pharma hit their fresh 52-week high during the day.
 Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
More     Less